Sandra Levy
ARTICLES BY THIS AUTHOR
- 6/24/2020
CVS Health expands testing capabilities in California amid rise in COVID-19 cases
CVS Health is adding 35 additional new drive-thru test sites to the 107 locations it has in California to address the rising number of COVID-19 cases. - 6/24/2020
NACDS promotes Christie Boutte to state advocacy role
Boutte's 20-year career includes chain pharmacy practice and key roles in government, as a clinical program manager at a health plan, and at the National Association of Chain Drug Stores. - 6/24/2020
Schnucks teams up with Foodshed.io to support local farms
Schnucks' partnership with Foodshed.io will bring local produce to the communities that the Midwest grocer serves. - 6/23/2020
CVS Health to sponsor Washington Spirit women's soccer league team
CVS Health will be the Washington Spirit's presenting sponsor, official health insurance sponsor and official pharmacy sponsor. - 6/23/2020
Novartis receives FDA nod for new indication of Cosentyx
The indication to treat non-radiographic axial spondyloarthritis is the fourth FDA-approved indication for Novartis’ Cosentyx. - 6/23/2020
NACDS holds virtual fly-in with administration, Congressional leaders
The National Association of Chain Drug Stores board of directors' virtual meeting with the administration and Congressional leaders centered on policies essential to COVID-19 response, as well as pharmacy reimbursement reforms. - 6/23/2020
Upsher-Smith debuts generic Edecrin
The ethacrynic acid tablet had a market value of roughly $17 million for the 12 months ended April 2020, according to IQVIA. - 6/23/2020
CVS Health launches Return Ready to get Americans back to worksites, campuses
CVS Health’s Return Ready offers organizations a customizable COVID-19 testing solution, clinical protocols and reporting to meet their unique needs. - 6/22/2020
AAM weighs in on trade rep's USMCA testimony
AAM welcomed testimony in which U.S. Trade Representative Robert Lightizer said the free trade agreement currently being negotiated will not contain a provision requiring 10-years of biologic exclusivity. - 6/22/2020
Bausch + Lomb inks deal with Stada, Xbrane for Lucentis biosimilar candidate
Bausch + Lomb will be responsible for sales, marketing, and other commercialization efforts for biosimilar Lucentis, following regulatory approval in the United States and Canada.
